Ipilimumab/nivolumabHypophysitis and adrenal insufficiency following off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1781卷 / 1期

关键词：

D O I：

10.1007/s40278-019-72030-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：207 / 207

相关论文

共 50 条

[1] Ipilimumab/nivolumabHypophysitis, hypothyroidism and adrenal insufficiency: case report
Reactions Weekly, 2021, 1852 (1) : 247 - 247
[2] Ipilimumab/levothyroxine sodium/nivolumabHypophysitis, adrenal insufficiency and syncopal episode: case report
Reactions Weekly, 2017, 1652 (1) : 159 - 159
[3] Ipilimumab/nivolumabHypophysitis leading to adrenal insufficiency and acute colonic pseudo-obstruction: case report
Reactions Weekly, 2023, 1986 (1) : 224 - 224
[4] MifepristoneAdrenal insufficiency following in off label use : case report
Reactions Weekly, 2024, 2039 (1) : 337 - 337
[5] Ipilimumab/nivolumabLack of efficacy following off label use : case report
Reactions Weekly, 2024, 2031 (1) : 208 - 208
[6] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2023, 1965 (1) : 258 - 258
[7] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2022, 1887 (1) : 396 - 396
[8] NivolumabHypophysitis, hypothyroidism and central adrenal insufficiency: case report
Reactions Weekly, 2019, 1770 (1) : 306 - 306
[9] NivolumabHypophysitis leading to secondary adrenal insufficiency: case report
Reactions Weekly, 2021, 1877 (1) : 313 - 313
[10] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2022, 1926 (1) : 277 - 277

← 1 2 3 4 5 →